Erschienen in:
28.06.2021 | COVID-19 | Editorial
Zur Zeit gratis
Covid-19 and Patients with IBD: Who Is at Highest Risk for Severe Complications?
verfasst von:
Sara Horst
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 4/2022
Einloggen, um Zugang zu erhalten
Excerpt
During the year 2020, GI physicians were faced with many questions, in particular how patients with inflammatory bowel disease (IBD) would be affected by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19). Research teams and organizations rapidly led intense efforts to quickly advance the understanding of the impact of COVID-19 for patients with IBD, including the formation of the Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease database (SECURE-IBD). This voluntary international registry enabled providers to gather and disseminate information about patients with IBD who developed a COVID-19 infection [
1]. …